Immunogenic Compositions for Use in Pneumococcal Vaccines
AssigneePfizer Inc.
InventorsDavid Cooper, Kathrin Ute Jansen, Michael William Pride
Life of this patent
Estimating the term…
Abstract
An object of the present invention is to provide immunogenic compositions for protection against S. pneumoniae, in particular against S. pneumoniae serogroup 9, while limiting the number of conjugates. The present invention thereforerelates to new immunogenic compositions for use in pneumococcal vaccines and to vaccination of human subjects, in particular infants and elderly, against pneumoccocal infections using said immunogenic compositions.
Claims15
An immunogenic composition comprising at least one glycoconjugate from S. pneumoniae serotype 9V for use in a method of immunizing a subject against infection by S. pneumoniae serotype 9N, 9A and/or 9L.
Dependencies are inferred from the claim text.